基于网络药理学与实验验证解析益气温阳活血方对心肌梗死大鼠的心脏保护机制
该研究采用网络药理学预测益气温阳活血方(YQHX)的活性成分靶点,并在心肌缺血大鼠模型中验证其心脏保护作用。网络分析获得141个潜在靶点,主要富集于凋亡相关通路及PI3K-AKT、MAPK通路。体内实验显示YQHX显著改善心功能、抑制心肌凋亡,上调Nrf2和HO-1表达并抑制JNK磷酸化。
要点
- YQHX通过多成分、多靶点、多通路发挥心脏保护作用。
- YQHX抗凋亡作用可能与调控Nrf2/HO-1和JNK-MAPK通路有关。
- 网络药理学预测结合体内实验验证是解析中药复方机制的有效策略。
核心结论
- YQHX的心脏保护作用依赖于多成分、多靶点和多通路机制,其抗凋亡效应可能通过调控Nrf2/HO-1和JNK-MAPK通路实现。
研究设计与样本
- 研究采用网络药理学预测YQHX化合物靶点并构建「草药-化合物-靶点」网络,同时使用心肌缺血大鼠模型进行体内验证。
- 靶点预测使用PharmMapper、Symmap和STITCH数据库,GO和KEGG富集分析使用DAVID数据库,蛋白互作网络使用STRING构建。
- 体内实验采用透射电镜观察凋亡小体,Western blotting检测关键候选靶点蛋白表达。
主要发现
- 网络药理学共获得141个潜在靶点,功能分析显示靶点主要与凋亡相关,PI3K-AKT和MAPK通路可能为关键功能通路。
- 网络枢纽基因包括ALB、TP53、AKT1、TNF、VEGFA、EGFR、MAPK1、CASP3、JUN、FN1、MMP9和MAPK8。
- 体内实验显示YQHX显著改善缺血大鼠心肌的心脏功能并抑制凋亡。
- YQHX可显著上调Nrf2和HO-1表达,并抑制JNK磷酸化。
临床怎么用
- 对于缺血性心脏病「气虚血瘀」证患者,YQHX可能通过抗凋亡机制发挥心脏保护作用,尤其涉及Nrf2/HO-1和JNK-MAPK通路。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
ETHNOPHARMACOLOGICAL RELEVANCE: "Qi deficiency and blood stasis" syndrome is one of the most common syndromes treated with Traditional Chinese Medicine among ischemic heart disease (IHD) patients in clinic. As a Chinese herbal formula with the function of tonifying Qi and activating blood, Yiqihuoxue Decoction (YQHX) has been frequently proven to be effective in the clinical treatment of IHD. AIM OF THE STUDY: The cardioprotective mechanisms of YQHX in treating ischemic heart disease were investigated, with emphasis on the key targets and pathways. MATERIALS AND METHODS: In the present study, the potential targets of compounds identified in YQHX were predicted using PharmMapper, Symmap, and STITCH databases, and a "herb-compound-target" network was constructed using Cytoscape. Subsequently, the GO and KEGG functional enrichment analyses were analyzed using the DAVID database. Furthermore, a protein-protein interaction network was constructed using STRING to obtain the key target information. Besides, we used a myocardial ischemia rat model to investigate the cardioprotective effects of YQHX. Transmission electron microscopy and Western blotting were used to observe apoptotic bodies and confirm protein expressions of key candidate targets, respectively. RESULTS: Network pharmacology showed that a total of 141 potential targets were obtained from these databases. The functional analysis results revealed that the targets of YQHX were largely associated with apoptosis, and the PI3K-AKT and MAPK pathways might represent key functional pathways. The hub genes of network include ALB, TP53, AKT1, TNF, VEGFA, EGFR, MAPK1, CASP3, JUN, FN1, MMP9, and MAPK8. In vivo, YQHX significantly improved cardiac function and suppressed apoptosis in ischemic rat myocardium. Furthermore, YQHX could significantly upregulate Nrf2 and HO-1 expression, and inhibit JNK phosphorylation. CONCLUSIONS: Based on network pharmacology and experimental evidence, this study proves that the cardioprotective effects and mechanisms of YQHX depend on multi-component, multi-target, and multi-pathway. In particular, YQHX exerts anti-apoptotic effects potentially by regulating the Nrf2/HO-1 and JNK-MAPK pathways.
引用
- Li FH, Guo SW, Zhan TW, et al. Integrating network pharmacology and experimental evidence to decipher the cardioprotective mechanism of Yiqihuoxue decoction in rats after myocardial infarction. J Ethnopharmacol. 2021. PMID: 33771641. doi:10.1016/j.jep.2021.114062
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。